Barrington Research Reaffirms Outperform Rating for Cinemark (NYSE:CNK)

Cinemark (NYSE:CNK)‘s stock had its “outperform” rating reissued by research analysts at Barrington Research in a research note issued to investors on Monday,Benzinga reports. They currently have a $36.00 target price on the stock. Barrington Research’s target price points to a potential upside of 24.80% from the stock’s current price.

Other analysts have also recently issued reports about the stock. Roth Mkm restated a “buy” rating and set a $37.00 target price on shares of Cinemark in a report on Thursday, April 23rd. Wall Street Zen upgraded Cinemark from a “sell” rating to a “hold” rating in a research report on Saturday, February 21st. Morgan Stanley lifted their target price on Cinemark from $28.00 to $30.00 and gave the stock an “equal weight” rating in a report on Thursday. The Goldman Sachs Group reaffirmed a “sell” rating and set a $22.00 target price on shares of Cinemark in a research report on Thursday, February 19th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cinemark in a report on Friday, March 27th. Ten investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Cinemark presently has a consensus rating of “Moderate Buy” and a consensus price target of $33.23.

Cinemark Stock Up 4.4%

CNK stock opened at $28.85 on Monday. The firm’s 50-day moving average is $28.22 and its two-hundred day moving average is $26.42. The company has a market capitalization of $3.37 billion, a price-to-earnings ratio of 25.60 and a beta of 1.03. Cinemark has a 52 week low of $21.60 and a 52 week high of $34.01. The company has a current ratio of 0.71, a quick ratio of 0.67 and a debt-to-equity ratio of 4.81.

Cinemark (NYSE:CNK) last announced its earnings results on Friday, May 1st. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.01). The firm had revenue of $643.10 million for the quarter, compared to the consensus estimate of $632.74 million. Cinemark had a return on equity of 41.31% and a net margin of 5.31%.Cinemark’s revenue for the quarter was up 18.9% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.32) EPS. On average, analysts forecast that Cinemark will post 2.14 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Melissa Thomas sold 7,944 shares of the firm’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $26.05, for a total value of $206,941.20. Following the completion of the sale, the executive vice president owned 159,416 shares of the company’s stock, valued at $4,152,786.80. This trade represents a 4.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 2.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Cinemark

Hedge funds have recently bought and sold shares of the business. EverSource Wealth Advisors LLC boosted its position in Cinemark by 118.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company’s stock worth $28,000 after acquiring an additional 507 shares during the period. Meeder Asset Management Inc. acquired a new position in shares of Cinemark in the 3rd quarter valued at about $63,000. Smartleaf Asset Management LLC increased its holdings in shares of Cinemark by 20.1% in the 3rd quarter. Smartleaf Asset Management LLC now owns 3,027 shares of the company’s stock valued at $83,000 after purchasing an additional 506 shares during the period. Leonteq Securities AG purchased a new stake in shares of Cinemark in the fourth quarter worth approximately $83,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Cinemark by 51.8% during the fourth quarter. GAMMA Investing LLC now owns 4,022 shares of the company’s stock worth $93,000 after purchasing an additional 1,372 shares during the period.

About Cinemark

Cinemark Holdings, Inc (NYSE: CNK) is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company’s core business involves the presentation of first-run feature films coupled with an array of in‐theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark’s exhibition portfolio encompasses both corporate‐owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large‐format halls.

The company’s product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.